NCT02528890View on ClinicalTrials.gov

Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Streptococcus B Carrier State Complicating Pregnancy
Interventions
OTHER

vaginal/anal swab for GBS from all participants

All eligible pregnant women, who meet the inclusion criteria and gave their informed consent to participate in the study has to complete a questionnaire and have a vaginal / anal swab taken to identify positive GBS carriers by PCR (polymerase chain reaction) test.

Trial Locations (1)

16100

Nazareth Hospital, Nazareth

All Listed Sponsors
lead

The Nazareth Hospital, Israel

OTHER

NCT02528890 - Group B Streptococcal Carrier State Prevalence Among Arab Pregnant Women in Northern Israel District | Biotech Hunter | Biotech Hunter